Neogenomics (NEO) Asset Utilization Ratio (2011 - 2026)

Neogenomics has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.55 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 32.8% year-over-year to 0.55; the trailing twelve-month figure through Mar 2026 stood at 0.55 (up 32.8% YoY), and the FY2025 full-year result was 0.49, up 21.91% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.55, up from 0.53 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.55 in Q1 2026, with the low at 0.26 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.38 across 5 years, with a median of 0.37 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio plunged 56.03% — and 2026, when it soared 32.8%.
• Neogenomics' Asset Utilization Ratio stood at 0.29 in 2022, then rose by 20.77% to 0.35 in 2023, then gained by 14.38% to 0.4 in 2024, then jumped by 32.03% to 0.53 in 2025, then increased by 3.63% to 0.55 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.55 (Q1 2026), 0.53 (Q4 2025), and 0.51 (Q3 2025), per Business Quant data.